Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Carmustine × Clear all

NCT00046852 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Phase 1/2 Completed

Infections, Multiple Myeloma, Neoplasms, Plasma Cell